Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).
about
Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentMammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory TractUniversal vaccine against respiratory syncytial virus A and B subtypes.Novel therapies and vaccines against the human respiratory syncytial virus.Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.
P2860
Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development of safe and effect ...... G protein core fragment (Gcf).
@ast
Development of safe and effect ...... G protein core fragment (Gcf).
@en
type
label
Development of safe and effect ...... G protein core fragment (Gcf).
@ast
Development of safe and effect ...... G protein core fragment (Gcf).
@en
prefLabel
Development of safe and effect ...... G protein core fragment (Gcf).
@ast
Development of safe and effect ...... G protein core fragment (Gcf).
@en
P2093
P2860
P1433
P1476
Development of safe and effect ...... G protein core fragment (Gcf)
@en
P2093
Byoung-Shik Shim
Cheol-Heui Yun
Dae Im Jung
In Su Cheon
Jae-Ouk Kim
Ji Eun Jang
Man Ki Song
Sung-Moo Park
Youngjoo Choi
P2860
P304
P356
10.1371/JOURNAL.PONE.0094269
P407
P50
P577
2014-04-15T00:00:00Z